Singol Voxel-MR Spectroscopy Choline Peak And Calcium Sensing Receptor Expression For Breast Cancer Diagnosis By A 3T MR Scanner | 1087
Journal of Cancer Science & Therapy
Like us on:
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Ca2+ as a primary extracellular signalling molecule, acts through the calcium sensing receptor (CaSR) and plays an important
role in cell signal transduction. Data from Northern blot analysis and immunohistochemical staining have shown that the
CaSR is expressed in normal human breast and breast ductal carcinoma. Alteration in choline phospholipid metabolism as
detected by MRI, is a common feature of breast and many other cancers. However understanding of the molecular mechanisms
that regulates ChoK is very limited. On the basis that CaSR-ChoK signalling plays an important role in breast cancer biology,
we correlated the MR spectroscopy (MRS) choline peak between CaSR-positive and negative breast cancer. Single-voxel MRS of
breast lesions (n=16) with a BI-RADS-5 at mammography or ultrasound were performed by a 3T MR scanner. Tumor morphology
and DCE-kinetics were evaluated on ACR BI-RADS lexicon. MRS findings were defined as positive by the visual inspection for
the presence or absence of choline peak and then compared with the pattern of CaSR by immunohistochemistry. We observed
in 67% of the breast lesions, the presence of choline peak and an high level expression of CaSR. In 27% of the lesions the choline
peak was absent with a low CaSR expression. These results support the hypothesis that CaSR represents an important role in the
production of choline in breast cancer, determinating an increase of his production when CaSR is expressed at high level and
implicating a no detectable choline peak when CaSR is not expressed, suggesting the possibility that CaSR-Cho signalling may
represent a potential biomarker for tumor targeting and therapeutic strategies.
Gabriella Baio received medical education at University of Pisa, completed medical radiology fellowship at University of Genoa. She received a
Research Grant in the Department of Radiology, National Cancer Institute-IST, in order to develop immunotargeting strategies for Lymphoma tumor
imaging by MR. She actually works at IRCCS-San Martino University Hospital-IST-National Cancer Institute, as a radiologist. She is involved in more
than 30 clinical cancer research projects in phase III and as a researcher in molecular imaging field, on many projects approved from the Ministry
of Health about breast, prostate and glioblastoma tumours by MR and Optical Imaging. She developed a prototype coil for in vivo imaging in small
animal model for a clinical 3T scanner, with GE Healthcare industry. Reviewer for Molecular Imaging and Biology Journal and Abstract Reviewer for
WMIC 2011 and 2012.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals